Mironid Announces Additional Non-Dilutive Funding Through an Early Stage Award from Innovate UK’s Biomedical Catalyst 2016
In All, PortfolioGlasgow, Scotland, 30th January 2017: Mironid® Limited, a leader in cell signalling-directed drug discovery, is delighted to start the New Year by initiating a £606K programme to expand its repertoire of proprietary LoAc® molecules. The work will be 70% funded by the UK’s innovation agency,…